BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Down 23.5% in February

BioSyent Inc. (OTCMKTS:BIOYF) saw a large drop in short interest in February. As of February 28th, there was short interest totalling 1,300 shares, a drop of 23.5% from the February 13th total of 1,700 shares. Based on an average daily trading volume, of 1,200 shares, the days-to-cover ratio is currently 1.1 days.

BioSyent Price Performance

BIOYF opened at $7.79 on Monday. BioSyent has a twelve month low of $5.93 and a twelve month high of $8.90. The firm has a 50 day moving average price of $7.70 and a 200-day moving average price of $7.89.

BioSyent Increases Dividend

The business also recently announced a dividend, which was paid on Friday, March 14th. Investors of record on Monday, March 3rd were issued a $0.0347 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a yield of 1.77%. This is a boost from BioSyent’s previous dividend of $0.03.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.